FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceuticals, in particular to the use of calcium germanophosphate Ca5GeP2O12 as an agent with the effect of destroying bacterial biofilms.
EFFECT: increasing the degree of suppression of the development of biofilms in biogenic materials based on calcium hydroxyapatite, stimulating the restoration of bone tissue defects.
2 cl, 3 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING NANO-SIZED CALCIUM-DEFICIENT CARBONATE-CONTAINING HYDROXYAPATITE | 2014 |
|
RU2588525C1 |
METHOD OF PRODUCING MODIFIED BIOCOATING ON TITANIUM IMPLANT (VERSIONS) | 2019 |
|
RU2693468C1 |
METHOD FOR PRODUCING NANOHYDROXYAPATITE | 2015 |
|
RU2614772C1 |
OSTEOPLASTIC MATERIAL FOR BONE DEFECT REPLACEMENT | 2024 |
|
RU2824989C1 |
BIORESORBABLE MATERIAL AND METHOD FOR PRODUCING THEREOF | 2017 |
|
RU2652429C1 |
PRODUCING METHOD OF NANOCRYSTALLINE SILICON-REPLACED HYDROXYAPATITE | 2012 |
|
RU2500840C1 |
METHOD FOR OBTAINING A MODIFIED BIOCOATING WITH Fe-Cu NANOPARTICLES ON A TITANIUM IMPLANT | 2021 |
|
RU2771813C1 |
BIOLOGICALLY ACTIVE NANOPARTICLES OF CARBONATE-SUBSTITUTED HYDROXYAPATITE, METHOD OF THEIR PRODUCTION AND COMPOSITIONS THAT INCLUDE THEM | 2006 |
|
RU2426690C2 |
COMPOSITE BIOMATERIAL BASED ON HYDROXYAPATITE AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2816008C1 |
BIORESORBABLE MATERIAL BASED ON AMORPHOUS HYDROXYAPATITE AND METHOD OF ITS OBTAINING | 2012 |
|
RU2510740C1 |
Authors
Dates
2021-11-11—Published
2021-03-24—Filed